Department of Biochemistry and Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
PLoS One. 2013;8(1):e54070. doi: 10.1371/journal.pone.0054070. Epub 2013 Jan 10.
We developed a novel drug screening system for anti-influenza A virus by targeting the M2 proton channel. In the SPP (Single Protein Production) system, E. coli cell growth occurs only in the presence of effective M2 channel inhibitors, and thus simple measurement of cell growth was used as readouts for drug screening. Two potential inhibitors for M2 (V27A) mutant were verified using this method, which inhibit both the mutant and wild-type M2 channels.
我们开发了一种针对流感 A 病毒 M2 质子通道的新型药物筛选系统。在 SPP(单一蛋白生产)系统中,只有在有效的 M2 通道抑制剂存在的情况下,大肠杆菌细胞才会生长,因此简单地测量细胞生长即可作为药物筛选的读数。使用这种方法验证了两种针对 M2(V27A)突变体的潜在抑制剂,它们能同时抑制突变型和野生型 M2 通道。